Results 181 to 190 of about 9,772 (228)
Some of the next articles are maybe not open access.

Triptans and SCAD

Journal of the American College of Cardiology, 2021
International ...
Perez, Justine   +5 more
openaire   +2 more sources

Triptans: Actions and Reactions

Headache: The Journal of Head and Face Pain, 2008
Subcutaneous sumatriptan is superior to placebo in achieving headache relief. Some commonly reported adverse events are paresthesias, tingling, and transient worsening of headache. Why do patients develop these symptoms? Our unique case may shed light on its actions.
Stephanie J, Nahas   +1 more
openaire   +2 more sources

Triptans Are All Different

Archives of Neurology, 2001
T HERE ARE 4 triptans currently available in theUnitedStates, and 3moreareexpectedto be approved by the Food and Drug Administration. Althoughtheyareall5-HT1B/1D (serotonin1B/1D) agonists, they each have slightly different pharmacokinetic characteristics and clinical strengths andweaknesses,andtheycanbeused in special ways to optimize migraine therapy.
A M, Rapoport, S J, Tepper
openaire   +2 more sources

Triptans Versus Analgesics

Headache: The Journal of Head and Face Pain, 2002
Objective .—To retrospectively assess patient preferences between triptans and analgesics in treating migraine headache. Methods .—The study assessed patient preferences for triptans versus commonly used migraine analgesic preparations.
openaire   +2 more sources

Triptans in childhood and adolescence

Seminars in Pediatric Neurology, 2001
The triptans are medications that are the most important advance, to date, in the treatment of migraine. Their use in adolescents is highlighted, including indications, dosages, benefits, and adverse effects.
openaire   +2 more sources

Treatment of Headache Following Triptan Failure After Successful Triptan Therapy

Current Treatment Options in Neurology, 2015
Triptans should remain the first choice in migraine abortive treatment. They are not always effective or adequate for specific patients. Before declaring a triptan in appropriate for a given patient, the provider ought to be analytical about the rationale and especially the use of objective efficacy outcome measures and ensure that treatment is ...
Marc E P, Lenaerts, James R, Couch
openaire   +2 more sources

Is There a Preferred Triptan?

Headache: The Journal of Head and Face Pain, 2002
David W, Dodick   +2 more
openaire   +2 more sources

THE TRIPTANE PROCESS

Science, 1943
V, Haensel, V N, Ipatieff
openaire   +2 more sources

The Triptans

CNS Drugs, 1999
Stewart J. Tepper, Alan M. Rapoport
openaire   +1 more source

Triptans with methysergide

2004
Abstract There is a discussion specially in France with the Drug Agency to prove that the contra-indications of Triptans/Methysergide are more theoretical than factual. In this study we present our experience concerning the contra-indication indicated by laboratories according to regulation. The contra-indications of the triptans include
openaire   +1 more source

Home - About - Disclaimer - Privacy